Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On Jim Watson's APOE status: genetic information is hard to hide.

Literature DB >> 18941475

On Jim Watson's APOE status: genetic information is hard to hide.

Dale R Nyholt, Chang-En Yu, Peter M Visscher.

Abstract

Entities: Gene Mutation

Mesh：

Substances：
Apolipoproteins E

Year: 2008 PMID： 18941475 PMCID： PMC2986051 DOI： 10.1038/ejhg.2008.198

Source DB: PubMed Journal: Eur J Hum Genet ISSN： 1018-4813 Impact factor: 4.246

× No keyword cloud information.

11 in total

Review 1. ApoE genotype accounts for the vast majority of AD risk and AD pathology.

Authors: Jacob Raber; Yadong Huang; J Wesson Ashford
Journal: Neurobiol Aging Date: 2004 May-Jun Impact factor: 4.673

2. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.

Authors: Lars Bertram; Matthew B McQueen; Kristina Mullin; Deborah Blacker; Rudolph E Tanzi
Journal: Nat Genet Date: 2007-01 Impact factor: 38.330

3. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Authors: Chang-En Yu; Howard Seltman; Elaine R Peskind; Nichole Galloway; Peter X Zhou; Elisabeth Rosenthal; Ellen M Wijsman; Debby W Tsuang; Bernie Devlin; Gerard D Schellenberg
Journal: Genomics Date: 2007-04-16 Impact factor: 5.736

Review 4. Research ethics and the challenge of whole-genome sequencing.

Authors: Amy L McGuire; Timothy Caulfield; Mildred K Cho
Journal: Nat Rev Genet Date: 2008-02 Impact factor: 53.242

5. In this issue: entering the era of high-density genome-wide association studies.

Authors: Eric M Reiman
Journal: J Clin Psychiatry Date: 2007-04 Impact factor: 4.384

6. The complete genome of an individual by massively parallel DNA sequencing.

Authors: David A Wheeler; Maithreyan Srinivasan; Michael Egholm; Yufeng Shen; Lei Chen; Amy McGuire; Wen He; Yi-Ju Chen; Vinod Makhijani; G Thomas Roth; Xavier Gomes; Karrie Tartaro; Faheem Niazi; Cynthia L Turcotte; Gerard P Irzyk; James R Lupski; Craig Chinault; Xing-zhi Song; Yue Liu; Ye Yuan; Lynne Nazareth; Xiang Qin; Donna M Muzny; Marcel Margulies; George M Weinstock; Richard A Gibbs; Jonathan M Rothberg
Journal: Nature Date: 2008-04-17 Impact factor: 49.962

7. Population genomics of human gene expression.

Authors: Barbara E Stranger; Alexandra C Nica; Matthew S Forrest; Antigone Dimas; Christine P Bird; Claude Beazley; Catherine E Ingle; Mark Dunning; Paul Flicek; Daphne Koller; Stephen Montgomery; Simon Tavaré; Panos Deloukas; Emmanouil T Dermitzakis
Journal: Nat Genet Date: 2007-09-16 Impact factor: 38.330

8. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

Authors: A J Slooter; M Cruts; S Kalmijn; A Hofman; M M Breteler; C Van Broeckhoven; C M van Duijn
Journal: Arch Neurol Date: 1998-07

9. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272

10. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Authors: Keith D Coon; Amanda J Myers; David W Craig; Jennifer A Webster; John V Pearson; Diane Hu Lince; Victoria L Zismann; Thomas G Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Douglas G Walker; Rivka Ravid; Christopher B Heward; Joseph Rogers; Andreas Papassotiropoulos; Eric M Reiman; John Hardy; Dietrich A Stephan
Journal: J Clin Psychiatry Date: 2007-04 Impact factor: 4.384

32 in total

Review 1. The tension between data sharing and the protection of privacy in genomics research.

Authors: Jane Kaye
Journal: Annu Rev Genomics Hum Genet Date: 2012-03-09 Impact factor: 8.929

2. Genetics and cardiovascular disease: a policy statement from the American Heart Association.

Authors: Euan A Ashley; Ray E Hershberger; Colleen Caleshu; Patrick T Ellinor; Joe G N Garcia; David M Herrington; Carolyn Y Ho; Julie A Johnson; Steven J Kittner; Calum A Macrae; Gia Mudd-Martin; Daniel J Rader; Dan M Roden; Derek Scholes; Frank W Sellke; Jeffrey A Towbin; Jennifer Van Eyk; Bradford B Worrall
Journal: Circulation Date: 2012-05-29 Impact factor: 29.690

3. Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.

Authors: Victoria S Marshe; Ilona Gorbovskaya; Sarah Kanji; Maxine Kish; Daniel J Müller
Journal: J Neural Transm (Vienna) Date: 2018-10-31 Impact factor: 3.575

On Jim Watson's APOE status: genetic information is hard to hide.

Review 1. ApoE genotype accounts for the vast majority of AD risk and AD pathology.

2. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.

3. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Review 4. Research ethics and the challenge of whole-genome sequencing.

5. In this issue: entering the era of high-density genome-wide association studies.

6. The complete genome of an individual by massively parallel DNA sequencing.

7. Population genomics of human gene expression.

8. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

9. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

10. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Review 1. The tension between data sharing and the protection of privacy in genomics research.

2. Genetics and cardiovascular disease: a policy statement from the American Heart Association.

3. Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.

Review 4. Routes for breaching and protecting genetic privacy.

Review 5. An overview of human genetic privacy.

6. Assessing the privacy risks of data sharing in genomics.

Review 7. Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

8. Enabling Privacy-Preserving GWASs in Heterogeneous Human Populations.

9. Public access to genome-wide data: five views on balancing research with privacy and protection.

Review 10. Ethical implications of the use of whole genome methods in medical research.